Gene response of human monocytic cells for the detection of antimigraine activity of feverfew extracts.
The herb feverfew is a folk remedy for various conditions, including inflammation, fever, psoriasis, rheumatism, and asthma. Like many herbal medicines, feverfew's mechanisms of action in the human body are largely unknown and its active ingredients remain elusive. Very often, different extraction methods of herb material produce different physical and biochemical properties and variation in clinical efficacy. We identified 3 major methods of extraction for feverfew aerial parts and used microarray technology to test the hypothesis that extracts produced by different methods elicit different gene expression profiles. We have identified approximately 200 genes that are consistently regulated by the 2 presumptive active antimigraine feverfew extracts but not associated with the inactive extract. Our results suggest that the presumptive active feverfew extracts potently stimulate more genes in human cells than the inactive extracts. We also identified several genes as unique signatures for these active extracts. All 3 feverfew extracts exhibited similar blockades on lipopolysaccharide-mediated TNF-alpha (tumor necrosis factor alpha) release, implicating that TNF-alpha is not responsible for the differences in the effects of the 3 feverfew extracts in human cells. In contrast, the active extracts more effectively suppressed CCL2 (also known as monocyte chemoattractant protein 1, MCP-1) than the inactive extracts, suggesting that CCL2 is a potential cellular target for feverfew's antimigraine effects.
Department of Genetics and Biochemistry, Jordan Hall 100, Clemson University, Clemson, SC 29634, USA. cchen@clemson.edu
Chin-Fu
CF
Chen
Albert Y
AY
Leung
D002460:Cell Line; D018932:Chemokine CCL2 / Q000096:biosynthesis; D020869:Gene Expression Profiling; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism; D008517:Phytotherapy; D010936:Plant Extracts / Q000494:pharmacology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D020903:Tanacetum parthenium; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
C111835:CCL2 protein, human; D018932:Chemokine CCL2; D010936:Plant Extracts; D014409:Tumor Necrosis Factor-alpha